Market Research Report Women Infertility Pipeline Review, H1 2017 | Page 3

- The pipeline guide features descriptive drug profiles for the pipeline products
which comprise, product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Women Infertility
(Women's Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Women Infertility (Women's Health) therapeutics
based on mechanism of action (MoA), drug target, route of administration (RoA)
and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Women
Infertility (Women's Health)
Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to
formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development
for Women Infertility (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most
promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Women
Infertility (Women's Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying
prospective partners with the most attractive projects to enhance and expand
business potential and